Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 17
Selected: 0
NCT IDTitle
NCT00295230Effects of Volume Guarantee With Pressure Supported vs. Synchronized Intermittent Mandatory Ventilation in VLBW Infants
NCT02617446The Clinical Study of the Safety and Efficacy of Istaroxime in Treatment of Acute Decompensated Heart Failure
NCT03217825Antihypertensive Effect of Different Doses of Rostafuroxin in Comparison With Losartan
NCT04706962TH1902 in Patients With Advanced Solid Tumors
NCT00934362Effect of Lucinactant on Mucus Clearance in Cystic Fibrosis Lung Disease
NCT00578734Lucinactant for Treatment of Acute Hypoxemic Respiratory Failure in Children up to Two Years Old
NCT04325035The Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock
NCT00807235Feasibility Study of Aerosolized Surfaxin in the Prevention of Respiratory Distress Syndrome (RDS) in Premature Infants
NCT02636868The Safety and Efficacy of Lucinactant for Inhalation in Premature Neonates 26 to 32 Weeks Gestational Age
NCT00215540SURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants.
NCT02528318Trial To Assess The Safety And Tolerability Of Lucinactant For Inhalation In Preterm Neonates 26 to 28 Weeks PMA
NCT00004500Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium Aspiration Syndrome
NCT02074059Trial to Assess the Safety and Tolerability of Lucinactant for Inhalation in Premature Neonates
NCT05975021A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C
NCT04264156A Safety and Efficacy Study of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age
NCT04389671The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19)
NCT00215553KL₄Surfactant Treatment in Patients With ARDS